Emotion, anxiolysis and memory

Human Psychopharmacology

Volumn 14, Issue SUPPL. 1, 1999, Pages

  Allain, H ^a   Bourin, M ^b   Reymann, J M ^a   Bentue Ferrer, D ^a   Patat, A ^c   Schuck, S ^a   Lieury, A ^d  

^a Inst de Rech Contre le Cancer IRCC   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Biotrial SA   (France)

^d UNIVERSITÉ RENNES 2   (France)

Author keywords

Anxiety; Benzodiazepines; Cognition; Emotion; Memory; Pharmacology

Indexed keywords

ALPIDEM; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; FLUMAZENIL; PSYCHOSTIMULANT AGENT; SURICLONE;

AFFECTIVE NEUROSIS; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY NEUROSIS; CONFERENCE PAPER; DEGENERATIVE DISEASE; DEMENTIA; DISEASE ASSOCIATION; EMOTION; HIPPOCAMPUS; HUMAN; INFORMATION; LIMBIC SYSTEM; MEMORY; MENTAL STRESS; NONHUMAN; PANIC; PRIORITY JOURNAL; PSYCHOTRAUMA; RECALL;

EID: 0032744209     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199908)14:1+3.0.CO;2-2     Document Type: Conference Paper

References (46)

1. Allain, H., Lieury, A., Reymann, J. M. et al. (1990). Le développement des médicaments promnésiants. Ann. Med. Int. (Paris), 141(supp. 1), 19-25.
2. Allain, H., Lieury, A. and Gandon, J. M. (1993). Psychopharmacology of memory components. Human Psychopharmacology, 4, 143-164.
3. Allman, P. (1992). Drug treatment of emotionalism following brain damage. Journal of the Royal Society of Medicine, 85, 423-424.
4. Andreasen, N. C. (1997). Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology. Science, 275, 1586-1593.
5. Bentue-Ferrer, D., Bureau, M., Patat, A. and Allain, H. (1996). Flumazenil. CNS Drug Review, 2, 390-414.
6. Blanchard, R. J., Ylidko, E. B., Redgers, R. J. and Blanchard, D. C. (1993). Defense system psychopharmacology. An ethological approach to the pharmacology of fear and anxiety. Behaviour Brain Research, 58, 155-165.
7. Bourin, M. (1997). Animal models of anxiety: are they suitable for predicting drug action in humans? Polish Journal of Pharmacology, 49, 79-84.
8. Bourin, M., Baker, G. B. and Bradwejn, J. (1998a). Neurobiology of panic disorder. Journal of Psychosomatic Research, 44, 163-180.
9. Bourin, M., Colombel, M. C. and Guitton, B. (1998b). Alprazolam 0·125 twice a day improves aspects of psychometric performance in healthy volunteers. Journal of Clinical Psychopharmacology, 18, 364-372.
10. Bourin, M., Colombel, M. C. and Malinge, M. (1995). Lorazepam 0·25 mg twice a day improves aspects of psychometric performance in healthy volunteers. Journal of Psychopharmacology, 9, 251-257.
11. Bourin, M., Couetoux du Tertre, A., Colombel, M. C. and Auget, J. L. (1994). Effects of low doses of lorazepam on psychometric tests in healthy volunteers. International Clinical Psychopharmacology, 9, 83-88.
12. Butler, L. D. and Spiegel, D. (1997). Trauma and memory. In Review of Psychiatry, Vol. 16, Dickstein, L. J. et al. (Eds.), American Psychiatric Press, pp. 13-53.
13. Cahill, L., Haier, R. J., Fallou, J., Alkire, M. T., Tang, C., Keator, D., Wu, J. and McGaugh, J. L. (1996). Amygdala activity at encoding correlated with long-term, free recall of emotional information. Proceedings of the National Academy of Science, 93, 8016-8021.
14. Cahill, L. and McGaugh, J. L. (1998). Mechanisms of emotional arousal and lasting declarative memory. Trends in Neuroscience, 21, 294-299.
15. Clement, Y. and Chapoutier, G. (1998). Biological bases of anxiety. Neuroscience and Biobehavioural Review, 22, 623-633.
16. Corodimas, K. P. and Ledoux, J. E. (1995). Disruptive effects of post-training perirhinal cortex lesions on conditioned fear: contributions of contextual cues. Behavioural Neuroscience, 109, 613-619.
17. Curran, H. V., Pooviboonsuk, P., Dalton, J. A. and Lader, M. H. (1998). Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology, 135, 27-36.
18. Danion, J. M., Weingartner, H., File, S. E. et al. (1993). Pharmacology of human memory and cognition: illustrations from the effects of benzodiazepines and cholinergic drugs. Journal of Psychopharmacology, 7, 371-377.
19. Davis, M. (1992). The role of the amygdala in fear and anxiety. Annual Review Neuroscience, 15, 353-375.
20. Eysenck, M. W. (1992). The nature of anxiety. In Handbook of Individual Differences: Biological Perspectives, Gale, A. and Eysenck, M. W. (Eds). John Wiley & Sons, New York, pp. 157-178.
21. Garcia, C., Philippot, P., Lacarelle, B., Valli, M., Rime, B., Bruguerolle, B. and Blin, O. (1997). Effects of lorazepam on film induced differentiated emotions in healthy volunteers. Fundamental and Clinical Pharmacology, 11, 466-475.
22. Gray, J. A. (1982). The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-hippocampal System. Oxford University Press, Oxford.
23. Hascoet, M. and Bourin, M. (1997). Anticonflict effect of alpidem as compared with the benzodiazepine alprazolam in rats. Pharmacology and Biochemistry of Behaviour, 56, 317-324.
24. Knight, R. T. (1996). Contribution of human-hippocampal region to novelty detection. Nature, 383, 256-259.
25. Ledoux, J. E. (1994). Emotion, memory and the brain. Scientific American, 6, 50-57.
26. Lieury, A., Boissiere, I., Jamet, E. and Marinkovic, K. (1997). Les mots grossiers sont-ils mieux mémorisés que les mots neutres? Le Langage et l'Homme, 32, 17-37.
27. Mahanty, N. K. and Sah, P. (1998). Calcium-permeable AMPA receptors mediate long-term potentiation in interneurons in the amygdala. Nature, 394, 683-686.
28. Mathews, A. and MacLeod, C. (1994). Cognitive approaches to emotion and emotional disorders. Annual Reviews of Psychology, 45, 25-30.
29. Mathews, A., Mogg, K., May, J. and Eysenck, M. W. (1989). Implicit and explicit memory bias in anxiety. Journal of Abnormal Psychology, 98, 236-240.
30. McNally (1997). Memory and anxiety disorders. Philosophical Transactions of the Roval Society, London, 352, 1755-1759.
31. McNaughton (1997). Cognitive dysfunction resulting from hippocampal hyperactivity. A possible cause of anxiety disorder. Pharmacology and Biochemistry of Behaviour, 56, 603-611.
32. McLeod, C. and McLaughlin, K. (1995). Implicit and explicit memory bias in anxiety: a conceptual replication. Behavioural Research Therapy, 33, 1-14.
33. Moran, P., Le Maitre, M. H., Philouze, V., Reymann, J. M., Allain, H. and Leonard, B. E. (1992). Reversal of learning and memory impairments following lesion of the nucleus basalis magnocellularis (NBM) by concurrent noradrenergic depletion using DSP4 in the rat. Brain Research, 595, 327-333.
34. Papez, J. W. (1937). A proposed mechanism of emotion. Archives of Neurological Psychiatry, 38, 725-743.
35. Patat, A., Klein, M. J., Surjus, A., Rostand, A. and Granier, J. (1991). Needy of effects of clobazam and lorazepam on memory and cognitive functions in healthy subjects. Human Psychopharmacology, 6, 229-241.
36. Patat, A., Perault, M. C., Vandel, B. et al. (1995). Assessment of the interaction between a partial agonist and a full agonist of benzodiazepine receptors, based on psychomotor and memory, in healthy volunteers. Journal of Psychopharmacology, 9, 91-101.
37. Paulsen, O. and Moser, E. I. (1998). A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity. Trends in Neuroscience, 21, 273-277.
38. Reidy, J. and Richards, A. (1997). Anxiety and memory: a recall bias for threatening words in high anxiety. Behaviour Research and Therapy, 35, 531-542.
39. Sabouraud, O. (1998). Cerveau et pensée. http:// www.med.univ-rennes1.fr/etud/pharmaco.
40. Schultz, W., Dayan, P. and Montague, P. R. (1997). A neural substrate of prediction and reward. Science, 275, 1593-1599.
41. Schück, S., Allain, H., Gandon, J. M., Patat, A., Millet, V. and Le Coz, F. (1998). Effect of bromazepam versus placebo on inhibition and waiting capacity in young women with traits of anxiety. Fundamental and Clinical Pharmacology, 12, 463-467.
42. Smolnick, R., Pietrwsky, R., Fehm, H. L. and Born, J. (1998). Enhanced selective attention after low-dose administration of the benzodiazepine antagonist flumazenil. Journal of Clinical Psychopharmacology, 18, 241-247.
43. Swanson, L. W. and Petrovich, G. D. (1998). What is the amygdala? Trends in Neuroscience, 21, 323-331.
44. Unrug-Neervoort, A., Van Luijtelaar, G. and Coenen, A. (1992). Cognition and vigilance: differential effects of diazepam and buspirone on memory and psychomotor performance. Neuropsychobiology, 26, 146-150.
45. Wees, H. G., Steinberg, G. and Pritzel, M. (1994). Mnestic disorders in long term high-dose diazepam abuse: a pilot study. European Journal of Psychiatry, 9, 254-259.
46. Williams, J. M. G., Watts, F. N., MacLeod, C. and Mathews, A. (1998). Cognitive Psychology and the Emotional Disorders. Wiley, Chichester.